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Introduction
Varicose vein (VV) surgery remains one of the
commonest surgical operations performed across
Europe. In the UK, it is also the commonest single
cause of medico-legal action against general and
vascular surgeons.1 Most of these actions appear to
arise because patients have a poor understanding of
the risks and benefits of intervention and are, there-
fore, surprised and aggrieved when the end-result
(cosmetic improvement and/or symptom relief) is less
satisfactory than they expected, or they suffer from
unexpected complications. In the majority of cases,
this situation arises because the surgeon has failed,
either consciously or sub-consciously, to properly
inform their patient of the risks and benefits. There
are a number of reasons why this might happen
including a lack of time and/or a wish not to cause
unnecessary patient anxiety. The latter may be due to a
genuine desire on the part of the surgeon not to alarm
the patient or for fear that admitting to complications
and occasional poor results may damage practice and
livelihood. Another reason why surgeons may not be
in a position to discuss their complication rates with
their patients is ignorance. As most surgeons do not
follow-up their VV patients, they usually lack valid
personal audit data with regard to medium and long-
term outcomes. This, together with a natural reluc-
tance to publish anything other than excellent results,
means that the true risks associated with VV surgery
are surprisingly poorly documented in the literature.
Probably, the most honest account of the morbidity
associated with VV surgery remains Corbett’s per-
sonal series of almost a 1000 limbs in ,600 patients.2
Although, in this large prospectively documented
consecutive series, major morbidity and complications
were extremely low, there was a significant incidence
of minor morbidity (17% patients) and, in particular,
neurological complications (11% patients).
In the UK, the commonest single cause of litigation
following VV surgery is alleged injury to cutaneous
sensory, specifically the saphenous and sural, nerves.1
However, as discussed above the true incidence and,
most importantly, natural history of such injuries are
poorly described. This means that surgeons have
limited information to pass on to their patients and
that the questions most frequently posed to ‘expert
witnesses’ in medico-legal cases are difficult to answer
with authority. For example, does objective evidence
of nerve injury constitute a ‘breach of duty’ or should
nerve injury be regarded as unavoidable consequence
of VV surgery that can occur even in the best of hands?
What is the true incidence of nerve injury after VV
surgery? Why should the majority of people with
nerve injury remain relatively asymptomatic while a
small minority develop a chronic dysaesthetic pain
syndrome such as saphenous nerve neuritis? If nerve
injury is apparent following VV surgery, what should
the patient be told about its likely resolution or
chronicity? Is specific treatment ever indicated; for
example, nerve repair? What reasonable steps can the
competent surgeon be expected to take in order to
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minimise the risk of nerve injury and can this risk ever
be reduced to zero?
The aim of this review is critically to analyse the
literature pertaining to nerve injury and VV surgery.
Firstly, in order to provide answers to these and other
important questions and, secondly, where answers are
not forthcoming, to suggest ways in which these gaps
in our knowledge might be filled.
Long saphenous surgery and the saphenous nerve
The standard operation for long saphenous vein (LSV)
VV involves disconnection of the saphenofemoral
junction (SFJ), stripping of the LSV to just below the
knee and multiple stab avulsions (MSAs) according to
preoperative marking.3 Several randomised, con-
trolled trials have proved beyond reasonable doubt
that failure to strip the LSV, at least to the level of the
knee, is associated with an unacceptable incidence of
recurrence4 and sub-optimal results in terms of health-
related quality of life (HR-QoL) and haemodynamic
improvement.5
Anatomy
The saphenous nerve (L3, 4) descends with the
superficial femoral artery and pierces the roof of the
lower quarter of the adductor canal where it comes to
lie deep to sartorius (Fig. 1). Here it gives off an infra-
patellar branch through that muscle to supply the skin
medial to the knee and distal to the patellar. The main
nerve pierces the deep fascia (fascia lata) just above the
knee and appears in the superficial tissues at the level
of the knee between sartorius and gracilis. At this
point, the nerve lies deep and posterior to the LSV,
separated from it by subcutaneous fat. Below this level
the nerve gets progressively more superficial and
anterior and eventually becomes juxtaposed to the
LSV. This occurs at a variable point but most
commonly about 2–3 cm below and medial to the
tibial tuberosity where the LSV receives the anterior
and posterior arch veins (the crow’s foot) and the Boyd
perforator. Below this level the nerve and its branches
are often wrapped around the LSV and its tributaries
making virtually impossible the removal of the latter
without damaging the former. The nerve supplies
branches to the skin of the medial surface of the calf
and ends in the skin of the medial surface of the foot.
The typical area of sensory loss caused by damage
to the saphenous nerve lies on the medial aspect of the
calf, above the medial malleolus (Fig. 2). Smaller areas
of patches of cutaneous numbness not within this area
are due to the interruption of minor cutaneous nerves
and, as such, are not true saphenous nerve injuries.
They occur usually as a consequence of MSAs and are
probably unavoidable.
What is the incidence of saphenous nerve injury if the LSV is
stripped to the ankle?
In the past, when standard practice was to strip the
LSV from ankle to groin, up to 50% of patients
suffered saphenous nerve injury on blind, objective
testing.6,7
Fig. 1. The relationship of the saphenous nerve and long
(great) saphenous vein in the lower limb. Reproduced with
kind permission from Gray’s Anatomy 38th Edition, Elsevier
Science Ltd, 1995 Fig 10.176 p 1596.
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Does the direction of stripping matter?
It has been suggested that stripping the LSV from
groin to ankle, rather than from ankle to groin, would
reduce the incidence of saphenous nerve injury. This is
because the nerve often straddles the point where
tributaries join the main LSV in an inverted ‘V’6 (Fig. 3)
so that, as the head of the stripper is drawn cranially,
the nerve is avulsed along with those tributaries. A
number of studies appear to confirm this contention
although incidence of sensory loss remains significant,
varying from 4 to 23% on objective testing.6,8,9
Is it necessary to strip the LSV?
Perhaps, because of concerns about nerve injury, as
well as haematoma formation, a significant proportion
of surgeons (up to 18% surveyed) chose not to strip
LSV at all.3 However, there is now overwhelming
evidence to show that failure to strip the LSV, at least
to the level of the knee (please see below), is associated
with an unacceptable rate of recurrence4 and a
negative impact upon deep venous reflux and HR-
QoL.5
Is stripping of the LSV to the knee associated with a lower
incidence of saphenous nerve injury?
As the saphenous nerve normally only joins the LSV in
the calf, and because the LSV in the calf is itself rarely
varicose, stripping of the LSV to just below the knee
has been viewed by many as the optimum balance of
risks and benefits.3 In a randomised trial comparing
partial (from groin to 4 cm below the level of the knee
joint) with complete (groin to ankle) LSV stripping
using the standard stripper, at 3 months the former
was associated with a significantly lower (7% vs. 39%)
incidence of saphenous nerve injury on blinded,
independent assessment. As additional procedures,
including short saphenous vein (SSV) surgery, perfor-
ating vein ligation and MSA were performed with
similar frequency in both groups it was reasonably
concluded that the improved results were due to the
partial LSV stripping.10 In another randomised trial
comparing LSV stripping to the knee with no strip-
ping, the overall prevalence of saphenous nerve injury
was 8% with no difference between groups. However,
in this study, details of how the assessments were
made and whether the assessor was blinded were not
provided.11 On the basis of these rather limited data, it
is now standard UK practice to strip to the level of the
knee joint.
Are there any disadvantages in only stripping the LSV to
the knee?
It is not known whether stripping the LSV to the knee,
as opposed to the ankle, is associated with a higher
incidence of recurrent VV. However, a significant
number of patients with VV do have significant reflux
Fig. 2. Typical area of sensory loss with saphenous nerve
injury.
Fig. 3. Arrangement of the branches of the saphenous nerve
straddling the LSV in the calf, leading to avulsion on cranial
directed stripping of the LSV from the ankle.
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in the below knee LSV and its major tributaries.
Furthermore, there are data to suggest that failure to
deal with such reflux leads to persistent incompetence
in medial calf perforators, and a failure to correct deep
reflux and overall venous haemodynamics.5,12 This is
an area worthy of further study.
Can the incidence saphenous nerve injury be reduced still
further?
Inversion stripping
Two early series suggested that the use of rigid (PIN)
stripper13 could virtually eliminate the incidence of
saphenous (and sural nerve injury) in the course of
LSV (and SSV) inversion stripping.14,15 In a random-
ised trial, Durkin et al.16 reported that 1 week post-
operatively there were three cases of saphenous nerve
injury in 33 patients undergoing conventional, and one
in 43 patients undergoing PIN, stripping to the knee
(9.1% vs. 2.3%). However, the assessment methods are
incompletely described and there was no longer-term
follow-up. A further randomised trial reported a 13%
incidence of saphenous nerve injury in the PIN group
compared with 17% (not significant) in the conven-
tional group.17 However, there are a number of factors
that limit the interpretation of these data. For example,
in patients stripped to the knee the incidence of
saphenous nerve injury was 19% (conventional) and
6% (PIN), while the incidence in those patients
stripped to the ankle was 11% (conventional) and
25% (PIN). Unfortunately, the numbers of patients are
too small to ascribe any statistical or clinical signifi-
cance to these apparent differences. It is also important
to note that as the data were analysed on an ‘intention
to treat’ basis, the PIN group includes patients in
whom inversion stripping (especially to the ankle) had
failed and there was recourse to the conventional
method. A more recent randomised trial comparing
conventional stripping with PIN stripping (68 patients
in each group, primary VV only) found no cases of
saphenous nerve injury in either group at 1 week
follow-up.18 In summary, while inversion stripping
may be an attractive technique and offer a number of
theoretical advantages over conventional stripping,
there are no compelling data to suggest that it reduces
saphenous nerve injury and larger, more methodolo-
gically robust, trials would be required to answer this
question definitively.
Sequential avulsion of the LSV
A randomised trial of comparing sequential avulsion
ðn ¼ 40Þ with conventional stripping of the LSV to the
knee ðn ¼ 40Þ found the former was associated with
significantly less pain at 1 week post-operatively.
However, when assessed at 6 weeks, there were only
three cases of minor sensory loss in the saphenous
nerve distribution, two of which were in the conven-
tional stripping group. Once again, how the assess-
ments were made is unclear.19
Radio frequency ablation (VNUS)
In this technique, the LSV is occluded by heating the
vessel wall to ,85 8C using radiofrequency energy.20
Registry data reported the presence of paraesthesia in
43/286 (15%) of limbs at 1 week, 21/233 (9.4%) at 6
months, 9/232 (3.9%) at 12 months and 8/142 (5.6%) at
2 years. When the LSV was ablated to the level of the
knee, paraesthesia was recorded in 5/179 (2.8%) and
5/111 (4.5%) limbs at 12 and 24 months. This compares
with 4/53 (7.5%) and 3/31 (9.7%), respectively when
the LSV was ablated to the level of the ankle. However,
these data were collected from 31 sites worldwide and
the assessment methods were not specified.21 Other
groups using the VNUS technique have reported: no
paraesthesia in a series of 41 legs;22 a prevalence of
8.5% (12/140);20 a prevalence of 33% (6/18) (inner
thigh) in limbs treated for recurrent LSV reflux.23 The
assessment methods are not described in these series
and how many represent true saphenous nerve injury
is unclear. In summary, there is no evidence that VNUS
significantly reduces the incidence of saphenous nerve
injury. Indeed, given the means by which VNUS
induces LSV obliteration, damage to the surrounding
tissues, including nerves, seems intuitively to be at
least as likely as with surgical stripping.
Endovenous laser therapy (EVLT)
EVLT uses pulsed light energy to obliterate the LSV. It
has been suggested that the low penetration of this
energy means EVLT is less likely than heat-based
techniques to damage surrounding tissues. Proebstle
et al.24 treated 31 legs without any evidence of nerve
injury. In a further series of 90 legs a single case of
paraesthesia involving the medial calf was noted but
had resolved at 6 weeks.25 Once again, the assessment
methods are not described.
Echo-guided foam sclerotherapy
A number of groups have reported a zero incidence of
saphenous nerve injury with this technique.26,27 But,
once again, the methods and rigour by which such
injuries were sought is unclear.
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If a patient complains of saphenous nerve injury after VV
surgery what should they be told about the natural history
and likely prognosis?
Given the apparent frequency of saphenous nerve
injury and its medico-legal implication, it is surprising
there are so few data on which to base an answer to
this fundamental question. Jones et al.11 reported an
8% prevalence (9/113 limbs) of saphenous nerve
injury 2 years post-operatively. Unfortunately, as no
early post-operative data were presented, it is not
possible to draw any conclusion regarding the natural
history. Common clinical experience suggests that in
most patients the area of paraesthesia improves over
time. However, there is no doubt that a small number
of patients go on to develop an extremely troublesome
dysthetic pain syndrome, sometimes called saphenous
neuritis. Unfortunately, the incidence, aetiology, natu-
ral history, prevention and management of the
condition are completely unknown. This is another
area in urgent need of systematic study. Suffice to say,
patients must be warned specifically of the small risk
of this unpleasant complication.
Is specific treatment indicated for saphenous nerve injury?
It has been suggested that the detection of saphenous
nerve injury in the early post-operative course should
prompt referral to a plastic surgeon for consideration
of nerve repair. To our knowledge, this view has no
evidence base. Furthermore, this advice would seem
to be quite inappropriate given the numbers of VV
operations performed in Europe, the likelihood that at
least 5–10% will develop some degree of nerve injury,
and the fact that most patients do not appear to be
unduly troubled. If one could identify, early on, the
small proportion of patients who will go on to develop
a saphenous neuritis then some form of intervention
may be warranted but, as has been pointed out
already, we are almost completely ignorant of this
important complication.
Short saphenous surgery and the sural nerve
Anatomy of the sural nerve
The sural nerve (S1,2) arises from the tibial nerve in the
popliteal fossa and then descends in the back of the leg
to the posterior surface of the lateral malleolus (Fig. 4).
At first it lies deep to the deep fascia on the lateral head
of gastrocnemius and then comes to lie in the groove
between the two heads of gastrocnemius lateral to the
SSV. In the middle third of the calf it is joined by the
peroneal communicating branch of the common
peroneal nerve and pierces the deep fascia to lie in
the superficial tissues. The sural nerve may pierce the
deep fascia with, below or (less commonly) above the
SSV. Behind the lateral malleolus it turns forward
along the lateral border of the foot and little toe. It
supplies the skin of the lower half of the posterior
surface of the leg, the lateral part of the dorsum of the
foot, and the lateral side of the little toe. The sural
nerve lies close and lateral to the SSV throughout its
length and is at risk during dissection of the
saphenopopliteal junction, stripping of the SSV, and
MSAs of the SSV and its tributaries.
What is the incidence of sural nerve injury following SSV
stripping?
Although, the evidence is by no means as strong as it is
for the LSV, stripping the SSV should reduce recur-
rence rates by disconnecting the mid-calf perforator
and communicating veins to the LSV system.28 Yet, it is
not part of standard practice, at least in the UK, largely
because of concerns over injuring the closely applied
sural nerve.3 This being the case, it is perhaps
surprising to discover that there is, in fact, very little
data in the literature to support this circumspection.
There are a number of case reports describing sural
nerve injury in the course of SSV surgery but, by
definition, the authors obviously view them as rare
events. Furthermore, these reports do not, for the most
part, relate the injuries to the total case-load.29,30 The
rest of the literature comprises small case series where
operations for SSVand LSVare often analysed together
and where the operative and assessment method-
ologies are often incompletely described. This makes
any interpretation extremely difficult. Most recently,
Rashid et al.31 reported on 59 patients undergoing
operations for recurrent varices in the popliteal fossa
and noted one case of sural nerve injury 6 weeks post-
operatively.
Is partial stripping of the SSV safer?
A study comparing complete SSV stripping with
stripping of only those segments found to be refluxing
by venous duplex (selective stripping), found evi-
dence of sural nerve injury in 21% (5/24 legs) and 0%
(0/20 legs), respectively. However, the description of
the operative techniques is extremely cursory and
neurological examination was only performed in 80%
of the complete and 75% of the selective group at an
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average of 8.9 m post-operatively. It is also not clear if
this was a blinded, independent assessment.32
Is inversion stripping safer?
As with the LSV, PIN stripping may or may not reduce
the incidence of sural nerve injury. Although two,
early, uncontrolled, series reported a zero incidence13,
15 both were small and included no independent or
objective neurological assessment.
Are sequential avulsions safer?
Many surgeons once they have confidently identified
and divided the SSV in the popliteal fossa, bend up the
knee so that a length of 5–10 cm SV can be drawn up
into the wound from the calf and excised. Some also
remove the SSV from the calf further down through
separate incisions. In theory this should be safer as the
vein can be cleared of any surrounding tissues under
direct vision but there is no evidence that it is, in fact
safer than ‘blind’ stripping. And, of course, as with the
LSV it is much less cosmetically satisfactory.
Does pre-operative imaging of the popliteal fossa reduce the
risk of sural nerve injury?
Anatomical variations are common in the popliteal
fossa and sural nerve damage is inevitable if it is
placed within the vein wall itself, a rare but docu-
mented occurrence.30 In the enclosed space of the
popliteal fossa other nerves, including the common
peroneal2 and tibial nerves are at risk of traction injury.
While pre-operative marking may make surgery more
precise and this may reduce the likelihood of nerve
injury, in general, there is no evidence at present to
support this contention.
Sural neuritis
A small number of patients with sural nerve injury go
on to develop an extremely unpleasant chronic pain
syndrome. However, we know even less about this
condition than we do about saphenous nerve neuritis.
Multiple avulsions and other cutaneous nerves
MSAs are by their nature blind procedures and the
cutaneous nerves, are therefore particularly at risk,
including the saphenous and sural nerves. Interest-
ingly, a randomised study comparing SF ligation alone
to partial LSV stripping found more reports of
numbness at 6 weeks in the ‘ligation alone’ group,
and the sensory deficit in the saphenous nerve
distribution persisted in 8% of patients at the 2 year
follow up, with no difference between the groups.11
Various areas of the leg are particularly at risk during
MSA. The common peroneal nerve is at risk as it winds
around the neck of the fibula, the tibial nerve and
vessels behind the medial malleolus and the saphe-
nous nerve in the medial calf.
Fig. 4. The relationship of the sural nerve and short (small)
saphenous vein in the lower limb. Reproduced with kind
permission from Gray’s Anatomy 38th Edition, Elsevier
Science Ltd, 1995 Fig 10.177 p 1596.
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Trans-illuminated powered phlebectomy
A recent article examined the safety and efficacy of
powered phlebectomy with or without preceding
saphenous procedures. Although, some of the treat-
ment groups contained small numbers of patients,
there was an overall incidence of ca. 23% neurological
deficit for all combinations of treatment.33 Clearly,
further comparative data are required before any firm
conclusion can be drawn about this new technique and
cutaneous nerve injury.
Recurrent varicose veins
Intuitively, one would imagine that operations for
recurrent VV are going to result in a higher incidence
of nerve injuries. However, there are almost no data in
the literature to confirm or refute this contention.2 A
study of recurrent VV surgery comparing compli-
cations after direct or indirect exposure of the SFJ
found two cases of numbness in the direct group and
three in the indirect group, but assessment methods
are poorly described and which nerves were affected is
uncertain.34
Subfascial endoscopic perforator surgery (SEPS)
Jugenheimer et al.35 reported an incidence of sural and
saphenous nerve injury of 2 and 10%, respectively. In
the North American Subfascial Endoscopic Perforator
Surgery (NASEPS) registry mid-term report,36 the
incidence of saphenous nerve injury was 7% (10/
146). A randomised trial of open compared to
endoscopic division of perforating veins found two
cases of nerve injury in the open approach group.37
However, these data are difficult to interpret because
SEPS is nearly always performed in conjunction with
LSV and/or SSV surgery.
Use of tourniquet in VV surgery
It has been suggested that the use of a tourniquet
might increase the incidence of nerve injury because of
direct compression, ischaemia, or difficulty in dis-
tinguishing nerve and vascular structures in a blood-
less field. In a randomised trial of no tourniquet versus
the Lofquist cuff tourniquet, 3/50 patients had
temporary saphenous nerve injury at 6 weeks, one of
whom was in the tourniquet group.38 A further
comparative trial using the same tourniquet found
no evidence of significant post-operative compli-
cations in either group. However, this was neither
randomised nor case-matched and post-operative
neurological complications were not objectively
assessed.39 In a series of 220 patients using a different
tourniquet there was a 3% prevalence of saphenous
nerve injury. However, these patients underwent
saphenofemoral ligation and LSV stripping prior to
placement of the tourniquet.40
Discussion
Given the frequency with which VV surgery is
performed, the apparent high incidence of nerve
injuries, that (at least in the UK) VV surgery is the
commonest single cause of litigation against general
and vascular surgeons, and that knowledge clearly has
a major impact upon practice, it is really quite
surprising to discover that the literature on this
important subject is so deficient. So, what is it safe to
conclude?
1. Cutaneous nerve injury can and does occur even in
the best of hands; its presence is not, therefore,
indicative of substandard care or a ‘breach of duty’
per se.
2. Having said that, it is mandatory that patients are
made aware of the frequency and possible long-
term consequences of these complications.
3. With regard to the LSV, stripping to just below the
level of the knee appears to afford the optimum
balance between undertaking an effective and
durable operation, while at the same time mini-
mising the risk of saphenous nerve injury.
4. With regard to the SSV, the current reluctance to
strip may based upon an exaggerated perception of
the risk of sural nerve injury; however, this is an
area where further research is urgently required.
5. The evidence that inversion stripping is associated
with a lower incidence of nerve injury than
conventional stripping is not compelling, although
the technique is attractive for other reasons.
6. With the exception of echo-guided foam sclerother-
apy, none of the newer, minimally invasive,
techniques appear to afford significant protection
against cutaneous nerve injury.
7. The natural history of saphenous and sural nerve
injury following VV surgery is unknown.
While the majority of patients undergoing VV
surgery enjoy an excellent result,41 and major morbid-
ity and mortality are rare, minor morbidity, particu-
larly cutaneous nerve injury, remains a common
problem. A thorough review of the literature has
revealed just how much we do not know about this
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important complication of VV and re-emphasised the
need for further research.
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